Jayna Shin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jayna Shin has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Heejin Jo
Johns Hopkins University School of Medicine, USA
3 shared publications - Sung-Min Jeon
Johns Hopkins University School of Medicine, USA
3 shared publications - Sung-Ung Kang
Johns Hopkins University School of Medicine, USA
3 shared publications - Eunice J. Kang
Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
2 shared publications - Ji-Yu Lee
Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
2 shared publications - Stanley Cho
Department of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY 14853, USA, USA
2 shared publications
Latest Publications
- Open Access
- 9 September 2026
- Published by MDPI AG in Preprints.org
Circulating PAR-Binding Proteins as Candidate Mediators of Age-Dependent Cognitive Decline
Aging is associated with systemic changes in circulating plasma proteins that influence tissue function. Heterochronic parabiosis and plasma transfer experiments in mice have established that exposure to young or old blood is sufficient to modulate neurogenesis, synaptic plasticity, and cognition, indicating that age-regulated plasma proteins contribute causally to brain aging phenotypes. In parallel, the most recent proteome-wide studies of poly(ADP-ribose) (PAR) signaling have identified hundreds of candidate proteins that interact with PAR through non-covalent PAR binding motifs, including proteins involved in DNA repair, stress responses, inflammation, and metabolism, which are known as key ageing-associated factors. Multiple plasma proteomic studies in humans have defined sets of proteins whose abundance differs between young and older adults, and cross-referencing these datasets suggests that a subset of age-regulated plasma proteins may have experimental and/or predicted PAR-binding capacity. This review integrates evidence from heterochronic parabiosis, PAR-binding proteome (PARome) studies and age-stratified plasma proteomics to examine whether PAR-binding plasma proteins can form a mechanistically relevant subset of circulating age-dependent factors. Here we review how altered levels of these proteins with age may interface with intracellular PAR signaling networks to influence brain plasticity, inflammatory tone, and metabolic resilience, providing a potential explanation for the beneficial effects of young plasma and the detrimental effects of old plasma observed in parabiosis.
- 9 September 2026
- Published by MDPI AG in Preprints.org
Open AccessCirculating PAR-Binding Proteins as Candidate Mediators of Age-Dependent Cognitive Decline
Aging is associated with systemic changes in circulating plasma proteins that influence tissue function. Heterochronic parabiosis and plasma transfer experiments in mice have established that exposure to young or old blood is sufficient to modulate neurogenesis, synaptic plasticity, and cognition, indicating that age-regulated plasma proteins contribute causally to brain aging phenotypes. In parallel, the most recent proteome-wide studies of poly(ADP-ribose) (PAR) signaling have identified hundreds of candidate proteins that interact with PAR through non-covalent PAR binding motifs, including proteins involved in DNA repair, stress responses, inflammation, and metabolism, which are known as key ageing-associated factors. Multiple plasma proteomic studies in humans have defined sets of proteins whose abundance differs between young and older adults, and cross-referencing these datasets suggests that a subset of age-regulated plasma proteins may have experimental and/or predicted PAR-binding capacity. This review integrates evidence from heterochronic parabiosis, PAR-binding proteome (PARome) studies and age-stratified plasma proteomics to examine whether PAR-binding plasma proteins can form a mechanistically relevant subset of circulating age-dependent factors. Here we review how altered levels of these proteins with age may interface with intracellular PAR signaling networks to influence brain plasticity, inflammatory tone, and metabolic resilience, providing a potential explanation for the beneficial effects of young plasma and the detrimental effects of old plasma observed in parabiosis.
- Open Access
- 6 February 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (2) , 194
Higher Purity of Phosphatidylserine Improves Human Cortical Neuron Function by Modulating SIRT1-PGC-1α Pathways
While phosphatidylserine (PS) is recognized for its neuroprotective properties, the effects of PS purity on human cortical neurons remain unexplored. This study investigates the effects of three different PS purities (15 µM of 50%, 70%, and 80%) on neuronal health using human-embryonic-stem-cell-derived cortical neurons. Our findings reveal that higher PS purity enhances the expression of key regulatory proteins Sirtuin 1 (SIRT1) and Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), known for their roles in neuroprotection and mitochondrial function. Specifically, 80% PS purity significantly increases SIRT1 and PGC-1α levels, suggesting that PS purity strengthens neuroprotective pathways and improves mitochondrial quality control. Through SIRT1 knockdown experiments, we demonstrate that PS-induced upregulation of PGC-1α is SIRT1 dependent, highlighting a SIRT1-PGC-1α regulatory axis that enhances mitochondrial health. In an amyloid-beta 1–42 (Aβ42)-induced Alzheimer’s disease (AD) model, PS treatment reduced cytotoxicity and countered the Aβ42-induced downregulation of SIRT1 and PGC-1α, particularly at 70% and 80% PS purity, indicating PS’s role in preserving neuronal viability and combating AD-like pathology. These results suggest that the biological activity of PS preparations in vitro can depend on purity, motivating future studies to define compositional determinants and bioavailability relevant to translational applications.
- 6 February 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (2) , 194
Open AccessHigher Purity of Phosphatidylserine Improves Human Cortical Neuron Function by Modulating SIRT1-PGC-1α Pathways
While phosphatidylserine (PS) is recognized for its neuroprotective properties, the effects of PS purity on human cortical neurons remain unexplored. This study investigates the effects of three different PS purities (15 µM of 50%, 70%, and 80%) on neuronal health using human-embryonic-stem-cell-derived cortical neurons. Our findings reveal that higher PS purity enhances the expression of key regulatory proteins Sirtuin 1 (SIRT1) and Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), known for their roles in neuroprotection and mitochondrial function. Specifically, 80% PS purity significantly increases SIRT1 and PGC-1α levels, suggesting that PS purity strengthens neuroprotective pathways and improves mitochondrial quality control. Through SIRT1 knockdown experiments, we demonstrate that PS-induced upregulation of PGC-1α is SIRT1 dependent, highlighting a SIRT1-PGC-1α regulatory axis that enhances mitochondrial health. In an amyloid-beta 1–42 (Aβ42)-induced Alzheimer’s disease (AD) model, PS treatment reduced cytotoxicity and countered the Aβ42-induced downregulation of SIRT1 and PGC-1α, particularly at 70% and 80% PS purity, indicating PS’s role in preserving neuronal viability and combating AD-like pathology. These results suggest that the biological activity of PS preparations in vitro can depend on purity, motivating future studies to define compositional determinants and bioavailability relevant to translational applications.
- Open Access
- 25 December 2025
- Published by MDPI AG in Preprints.org
Higher Purity of Phosphatidylserine Improves Human Cortical Neuron Function by Modulating SIRT1-PGC-1α Pathways
While phosphatidylserine (PS) is recognized for its neuroprotective properties, the effects of PS purity on human cortical neurons remains unexplored. This study investigates three different PS purities (15 µM of 50%, 70%, and 80%) on neuronal health using human embryonic stem cell-derived cortical neurons. Our findings reveal that higher PS purity enhances the expression of key regulatory proteins SIRT1 and PGC-1α, known for their roles in neuroprotection and mitochondrial function. Specifically, 80% purity PS significantly increases SIRT1 and PGC-1α levels, suggesting that PS purity strengthens neuroprotective pathways and improves mitochondrial quality control. Through SIRT1 knockdown experiments, we demonstrate that PS-induced upregulation of PGC-1α is SIRT1-dependent, highlighting a SIRT1-PGC-1α regulatory axis that enhances mitochondrial health. In an amyloid-beta (Aβ42)-induced Alzheimer’s disease (AD) model, PS treatment, particularly at 70% and 80% purity, reduced cytotoxicity and countered the Aβ42-induced downregulation of SIRT1 and PGC-1α, indicating PS’s role in preserving neuronal viability and combating AD-like pathology. Further analyses showed that PS purity modulates mitochondrial fission and fusion gene expression, which are often dysregulated in neurodegenerative diseases, thereby restoring mitochondrial integrity and reducing oxidative stress. These results emphasize the importance of PS purity in human cortical neuron models and suggest that PS, as a nutritional supplement or a potential treatment for early Alzheimer’s patients, could be applied effectively in neurodegeneration strategies, targeting mitochondrial dysfunction.
- 25 December 2025
- Published by MDPI AG in Preprints.org
Open AccessHigher Purity of Phosphatidylserine Improves Human Cortical Neuron Function by Modulating SIRT1-PGC-1α Pathways
While phosphatidylserine (PS) is recognized for its neuroprotective properties, the effects of PS purity on human cortical neurons remains unexplored. This study investigates three different PS purities (15 µM of 50%, 70%, and 80%) on neuronal health using human embryonic stem cell-derived cortical neurons. Our findings reveal that higher PS purity enhances the expression of key regulatory proteins SIRT1 and PGC-1α, known for their roles in neuroprotection and mitochondrial function. Specifically, 80% purity PS significantly increases SIRT1 and PGC-1α levels, suggesting that PS purity strengthens neuroprotective pathways and improves mitochondrial quality control. Through SIRT1 knockdown experiments, we demonstrate that PS-induced upregulation of PGC-1α is SIRT1-dependent, highlighting a SIRT1-PGC-1α regulatory axis that enhances mitochondrial health. In an amyloid-beta (Aβ42)-induced Alzheimer’s disease (AD) model, PS treatment, particularly at 70% and 80% purity, reduced cytotoxicity and countered the Aβ42-induced downregulation of SIRT1 and PGC-1α, indicating PS’s role in preserving neuronal viability and combating AD-like pathology. Further analyses showed that PS purity modulates mitochondrial fission and fusion gene expression, which are often dysregulated in neurodegenerative diseases, thereby restoring mitochondrial integrity and reducing oxidative stress. These results emphasize the importance of PS purity in human cortical neuron models and suggest that PS, as a nutritional supplement or a potential treatment for early Alzheimer’s patients, could be applied effectively in neurodegeneration strategies, targeting mitochondrial dysfunction.